Kiora Pharmaceuticals
(NASDAQ) KPRX
Kiora Pharmaceuticals Financials at a Glance
Market Cap
$11.30M
Revenue (TTM)
$0.00
Net Income (TTM)
$10.84M
EPS (TTM)
$-2.79
P/E Ratio
-1.03
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$2.50
Volume
210,659.435
Open
$2.67
Price
$2.50
Volume
210,659.435
Open
$2.67
Previous Close
$2.86
Daily Range
$2.45 - $2.77
52-Week Range
$1.76 - $4.18
Dividend
$0.00
Beta (Volatility)
0.80 (Low)
Price
$2.50
Volume
210,659.435
Open
$2.67
Previous Close
$2.86
Daily Range
$2.45 - $2.77
52-Week Range
$1.76 - $4.18
KPRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kiora Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
13
CEO
Brian Matthew Strem, PhD
Website
www.kiorapharma.comHeadquarters
Encinitas, UT 84105, US
KPRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-52%
Return on Capital
-46%
Return on Assets
-45%
Earnings Yield
-97.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.30M
Shares Outstanding
3.95M
Volume
210.66K
Short Interest
0.00%
Avg. Volume
501.60K
Financials (TTM)
Gross Profit
$24.80K
Operating Income
$9.46M
EBITDA
$9.43M
Operating Cash Flow
$9.96M
Capital Expenditure
$110.79K
Free Cash Flow
$10.07M
Cash & ST Invst.
$17.09M
Total Debt
$368.26K
Kiora Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$10.51K
N/A
Gross Margin
0.00%
N/A
Market Cap
$11.30M
N/A
Market Cap/Employee
$941.57K
N/A
Employees
12
N/A
Net Income
$6.52M
-54.3%
EBITDA
$2.62M
-9.2%
Quarterly Fundamentals
Net Cash
$16.72M
-37.5%
Accounts Receivable
$3.32M
+451.6%
Inventory
$0.00
N/A
Long Term Debt
$203.80K
+502.7%
Short Term Debt
$164.46K
+604.2%
Return on Assets
-44.67%
N/A
Return on Invested Capital
-45.87%
N/A
Free Cash Flow
$2.26M
-2.3%
Operating Cash Flow
$2.18M
+3.2%